EUVIMEDUpptäck EUVIMED
Crossref

Efficacy Evaluation of Right‐Heart Contrast Echocardiography Combined With the Valsalva Manoeuvre in Screening for Patent Foramen Ovale in Patients With Migraine Without an Identified Secondary Cause

Haijuan Gu, Jiesheng Xia, Zhenhua Xu, Jianwei Shi

Echocardiography · 2026-07 · 43 (7)

DOI: 10.1111/echo.70542 ↗

At a glance

Journal article in Echocardiography, published online on 2026-07-02. Written by Haijuan Gu and 3 co-authors. Institution: Department of Ultrasound, Nantong Haimen People's Hospital, Nantong, Jiangsu, China. Major MEDLINE topics: Foramen Ovale, Patent, Valsalva Maneuver, Echocardiography, Migraine Disorders. 31 references. Funded by: Nantong Municipal Science and Technology Bureau Social and Livelihood Project.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Objective

This study aimed to validate the efficacy of right‐heart contrast echocardiography (RHCE) combined with the Valsalva manoeuvre for screening for patent foramen ovale (PFO) in patients with migraine without an identified secondary cause.

Methods

We enrolled 232 patients between April 2023 and December 2024. All underwent RHCE with a standardized Valsalva manoeuvre, using transoesophageal echocardiography (TEE) as the reference standard. Diagnostic performance, consistency and correlations were analyzed. A major methodological limitation of this study was that intrathoracic pressure during the Valsalva manoeuvre was not quantitatively measured.

Results

The PFO‐positive rate was 61.64% (143/232). Using TEE as the reference standard, the sensitivity was 92.03%, the specificity was 85.14%, the accuracy was 89.22% and the area under the curve was 0.886 (95% confidence interval: 0.841–0.931). Discordant results occurred in 26 patients. The prevalence of PFO was significantly higher in patients with migraine with aura than in those without aura (70.59% vs. 54.72%, p < 0.05).

Conclusion

Right‐heart contrast echocardiography combined with the Valsalva manoeuvre is a non‐invasive, convenient and effective method for PFO screening in patients with migraine without an identified secondary cause, especially those with aura.

Subjects

MeSH terms (MEDLINE)

Foramen Ovale, PatentValsalva ManeuverEchocardiographyMigraine DisordersHumansFemaleMaleSensitivity and SpecificityAdultReproducibility of ResultsContrast MediaMiddle AgedEchocardiography, Transesophageal

Author keywords

echocardiographyforamen ovalemigraine disorderspatent

Substances

Contrast Media

Authors and institutions

  • Department of Ultrasound, Nantong Haimen People's Hospital, Nantong, Jiangsu, China.
  • Department of Neurology, Nantong Haimen People's Hospital, Nantong, Jiangsu, China.

Funding

  • Nantong Municipal Science and Technology Bureau Social and Livelihood Project

Cite

APA

Gu, H., Xia, J., Xu, Z., & Shi, J. (2026). Efficacy Evaluation of Right‐Heart Contrast Echocardiography Combined With the Valsalva Manoeuvre in Screening for Patent Foramen Ovale in Patients With Migraine Without an Identified Secondary Cause. Echocardiography, 43(7). https://doi.org/10.1111/echo.70542

Vancouver

Gu H, Xia J, Xu Z, Shi J. Efficacy Evaluation of Right‐Heart Contrast Echocardiography Combined With the Valsalva Manoeuvre in Screening for Patent Foramen Ovale in Patients With Migraine Without an Identified Secondary Cause. Echocardiography. 2026;43(7). doi:10.1111/echo.70542

BibTeX
@article{Gu2026,
  author = {Gu, Haijuan and Xia, Jiesheng and Xu, Zhenhua and Shi, Jianwei},
  title = {Efficacy Evaluation of Right‐Heart Contrast Echocardiography Combined With the Valsalva Manoeuvre in Screening for Patent Foramen Ovale in Patients With Migraine Without an Identified Secondary Cause},
  journal = {Echocardiography},
  year = {2026},
  volume = {43},
  number = {7},
  doi = {10.1111/echo.70542}
}
Start for free →